Figure 3.

Least-squares mean differences and 95% confidence intervals between the OROS® hydromorphone and controlled-release (CR) morphine groups at end of the sustained-release (SR) phase.

Hanna et al. BMC Palliative Care 2008 7:17   doi:10.1186/1472-684X-7-17
Download authors' original image